Literature DB >> 18653725

Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion.

Paolo Tessari1, Edward Kiwanuka, Monica Vettore, Rocco Barazzoni, Michela Zanetti, Diego Cecchet, Rocco Orlando.   

Abstract

We explored the mechanism(s) of increased aromatic amino acids concentrations in liver cirrhosis using phenylalanine (Phe) and tyrosine (Tyr) isotope infusions in male patients with compensated cirrhosis (five in Child Class A, three in B) and in eight matched healthy controls, in both postabsorptive and fed states. After a baseline period, a standard liquid mixed meal was fed continuously over 4 h. Both a "plasma" and an intracellular model were employed. In the patients, steady-state Phe and Tyr concentrations were approximately 30-50% greater, and rates of Phe appearance (Ra) (plasma model), Tyr Ra, and Phe hydroxylation (Hy; both models) were approximately 25 to >100% greater than in controls in both states. Meal ingestion increased (P<0.05 or less vs. basal) Phe and Tyr concentrations, Phe and Tyr Ra, Phe Hy, and % Tyr Ra not deriving from Hy in both groups. Hy and Tyr Ra remained>50% greater (P<0.04 to P<0.01) in patients, whereas Phe Ra was more modestly increased. Phe utilization for protein synthesis increased similarly in both groups. Tyr clearance was normal, whereas Phe clearance tended to be lower (P=0.09, intracellular model) in the patients. In summary, in compensated liver cirrhosis studied under fasted and fed states, 1) Tyr Ra is increased; 2) Phe Hy and Phe Ra (plasma model) are increased; 3) Tyr clearance is normal; and 4) Phe clearance is slightly decreased. In conclusion, in cirrhosis increased total tyrosine Ra and hydroxylation contribute to fasting and postmeal hypertyrosinemia, whereas the mechanism(s) responsible for the hyperphenylalaninemia may include both increased production and decreased disposal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18653725     DOI: 10.1152/ajpgi.00355.2007

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  12 in total

1.  Correlation between plasma amino acid profiles and the various stages of hepatitis B infection.

Authors:  J Yang; J He; H Cao; X Zhao; S Fu; H Lu; Y Chen; X Pan; L Li
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08       Impact factor: 3.267

2.  Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis.

Authors:  Cynthia Tsien; Gangarao Davuluri; Dharmvir Singh; Allawy Allawy; Gabriella A M Ten Have; Samjhana Thapaliya; John M Schulze; David Barnes; Arthur J McCullough; Marielle P K J Engelen; Nicolaas E P Deutz; Srinivasan Dasarathy
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

Review 3.  Sarcopenia in chronic liver disease: mechanisms and countermeasures.

Authors:  Sophie L Allen; Jonathan I Quinlan; Amritpal Dhaliwal; Matthew J Armstrong; Ahmed M Elsharkawy; Carolyn A Greig; Janet M Lord; Gareth G Lavery; Leigh Breen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-25       Impact factor: 4.052

4.  Prematurity reduces citrulline-arginine-nitric oxide production and precedes the onset of necrotizing enterocolitis in piglets.

Authors:  Jason L Robinson; Victoria A Smith; Barbara Stoll; Umang Agarwal; Muralidhar H Premkumar; Patricio Lau; Stephanie M Cruz; Rodrigo Manjarin; Oluyinka Olutoye; Douglas G Burrin; Juan C Marini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-07-26       Impact factor: 4.052

Review 5.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

6.  A low postabsorptive whole body protein balance is associated with markers of poor daily physical functioning in Chronic Obstructive Pulmonary Disease.

Authors:  Clayton L Cruthirds; Nicolaas E P Deutz; Rajesh Harrykissoon; Anthony J Zachria; Mariëlle P K J Engelen
Journal:  Clin Nutr       Date:  2022-03-03       Impact factor: 7.324

7.  Consilience in sarcopenia of cirrhosis.

Authors:  Srinivasan Dasarathy
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-05-31       Impact factor: 12.910

8.  Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients.

Authors:  Jing Wang; Yang Wang; Xu Zhang; Jiaqi Liu; Qianpeng Zhang; Yu Zhao; Jinghua Peng; Qin Feng; Jianye Dai; Shujun Sun; Yufeng Zhao; Liping Zhao; Yongyu Zhang; Yiyang Hu; Menghui Zhang
Journal:  Front Microbiol       Date:  2017-11-13       Impact factor: 5.640

9.  Changes in hepatic metabolic profile during the evolution of STZ-induced diabetic rats via an 1H NMR-based metabonomic investigation.

Authors:  Minjiang Chen; Hong Zheng; Min Xu; Liangcai Zhao; Qianqian Zhang; Jingjing Song; Zhongwei Zhao; Siming Lu; Qiaoyou Weng; Xulu Wu; Weibin Yang; Xiaoxi Fan; Hongchang Gao; Jiansong Ji
Journal:  Biosci Rep       Date:  2019-04-23       Impact factor: 3.840

10.  Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients.

Authors:  David Pj van Dijk; Marcel Cg van de Poll; Alastair Gw Moses; Thomas Preston; Steven Wm Olde Damink; Sander S Rensen; Nicolaas Ep Deutz; Peter B Soeters; James A Ross; Kenneth Ch Fearon; Cornelis Hc Dejong
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-20       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.